Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

5.780 -0.140 (-2.37%)
Streaming Delayed Price Updated: 3:23 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares increased by 88.08% to $5.61 during Thursday's regular session. As of 12:30 EST, Ensysce Biosciences's stock is... 
Via Benzinga
20 Stocks Moving in Monday's Pre-Market Session
Gainers CF Acquisition Corp. VI (NASDAQ: CFVI) rose 23.6% to $14.75 in pre-market trading on continued strength following the SPACs announcement of a merger with Rumble. Digital... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Biofrontera (NASDAQ:BFRI) shares ... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down... 
Via Benzinga
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Ardelyx (NASDAQ:ARDX) shares rose 25.87% to $1.44 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 215.1 million... 
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's... 
Via Benzinga
Topics Intellectual Property
CRM Stock: 9 Reasons Why Salesforce Shares Are Sliding Lower Today
Salesforce (CRM) stock is falling on Wednesday following the release of the e-commerce company's Q3 fiscal 2022 earnings report. 
Via InvestorPlace
ARDX Stock Alert: The IBS Drug News Sending Ardelyx Shares Soaring Today
Ardelyx (ARDX) stock is soaring higher on Wednesday following an update concerning the company's ISB-C treatment in adults. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3... 
Via Benzinga
Citi, Ladenburg React Positively On Ardelyx's IBS-C Treatment Launch Plans
Citigroup 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, traders! We're starting off the day right with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a... 
Via Benzinga
Ardelyx's Return On Capital Employed Insights
According to Benzinga Pro data, during Q3, Ardelyx (NASDAQ:ARDX) posted sales of $1.17 million. Earnings were up 5.79%, but Ardelyx still reported an overall loss of $42.24... 
Via Benzinga
Ardelyx, Inc. (NASDAQ:ARDX) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 10/28/2021 -- Certain directors of Ardelyx, Inc are under investigation over possible breaches of fiduciary duties. 
Via SBWire
Topics Lawsuit
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tenet Healthcare (NYSE:THC) stock r... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Statera BioPharma (NASDAQ:STAB) shares rose 16.9% to $3.32 during Friday's regular session. The market value of their outstanding shares is at $91.7 million.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87.... 
Via Benzinga
Kessler Topaz Meltzer & Check, LLP:  Important Deadline Reminder for Ardelyx Inc. Investors in Securities Fraud Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
CLASS ACTION UPDATE for ARDX, ANVS and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / September 28, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
SHAREHOLDER ALERT: ARDX LIVE SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / September 28, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud
LAWSUITS FILED AGAINST ARDX, HYRE and WDH - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / September 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Initial Public Offering Lawsuit
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ARDX, ANVS and VIEW
NEW YORK, NY / ACCESSWIRE / September 27, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ARDX, ATIP and HNST
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
Topics Initial Public Offering Lawsuit
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ARDX, SESN and SAVA
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud
CLASS ACTION UPDATE for OTLY, ARDX and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
ARDX Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ardelyx, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: September 28, 2021
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.